Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Neuraxpharm Arzneimittel GmbH

https://www.neuraxpharm.de/

Latest From Neuraxpharm Arzneimittel GmbH

Who’s Hired? Neuraxpharm Appoints New Country Manager For Spain

Neuraxpharm has nabbed its second Almirall ex-employee in recent weeks, appointing Alfredo Barón as its new country manager for Spain. Plus, multiple trade groups expand their ranks and Perrigo promotes Alison Ives to chief scientific officer.

Executive Changes Leadership

Neuraxpharm Expands In Switzerland With New Local Head

Neuraxpharm has appointed Jörg Gärtner to lead its business in Switzerland, as the CNS specialist prepares to roll out its medical cannabis portfolio in the region.

Executive Changes Strategy

Who’s Hired? Neuraxpharm, Lupin And ANI Announce Appointments

Neuraxpharm, Lupin and ANI have announced changes within their leadership teams, while board members have joined industry associations Medicines for Europe and Australia’s GBMA.

Executive Changes Leadership

Neuraxpharm’s Brain Acquisition Stems From Expansion Ambitions

Privately-owned Neuraxpharm has found another company to give it further access to a new European market, picking up Athens-based Brain Therapeutics. It aims now to introduce its Buccolam (midazolam) in Greece.

M & A Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
    • OTC, Consumer
UsernamePublicRestriction

Register